Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2025 11:54 ET | Source: NeuExcell Therapeutics

NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma

NeuExcell’s NXL-004, first in situ conversion gene therapy, shows promising safety and efficacy in 11 GBM patients at ESMO Asia 2025
December 10, 2025 09:20 ET | Source: Ocugen

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
December 05, 2025 04:16 ET | Source: Research and Markets

$3.5 Bn Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035 Cell Therapy, Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification,...
December 05, 2025 04:14 ET | Source: Research and Markets

$16.5 Bn Gene Therapy Market Industry Trends and Global Forecasts to 2035 by Therapeutic Area, Vector, Therapy, Gene Delivery Method, RoA, Leading Market Players and Sales Forecast

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method,...
December 01, 2025 09:56 ET | Source: Research and Markets

Gene Editing Technology Trends and Forecast Report 2025: A $10+ Billion Market by 2030, Driven by Technological Advancements, Personalized Medicine Demand, and Rising Genetic & Chronic Disease Burden

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 28, 2025 07:45 ET | Source: Research and Markets

Huntington's Disease Market Opportunity Assessment and Forecast Report

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Huntington's Disease: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM and...
November 26, 2025 07:28 ET | Source: Research and Markets

Gene Therapy Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 787 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
November 24, 2025 08:55 ET | Source: SNS Insider pvt ltd

Viral Vector Manufacturing Market to Surpass USD 10.65 Billion by 2033, Driven by Surging Gene Therapy Pipelines and Advanced Vector Engineering | SNS Insider

Austin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Viral Vector Manufacturing Market Size & Growth Analysis: According to a comprehensive report by SNS Insider, the Viral Vector Manufacturing Market...
November 21, 2025 07:07 ET | Source: Research and Markets

U.S. Cell and Gene Therapy CDMO Market Trends Analysis Report 2025-2033: Gene & CAR-T Therapy Boom Drives Demand for CDMO Partnerships and Specialized Manufacturing Capacity

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy,...
November 20, 2025 08:00 ET | Source: Medidata Solutions, Inc.

Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Caidya, a leading...